Chang-Chao Su, Chu-Kuang Chou, Arvind Mukundan, Riya Karmakar, Binusha Fathima Sanbatcha, Chien-Wei Huang, Wei-Chun Weng, Hsiang-Chen Wang
{"title":"Capsule Endoscopy: Current Trends, Technological Advancements, and Future Perspectives in Gastrointestinal Diagnostics.","authors":"Chang-Chao Su, Chu-Kuang Chou, Arvind Mukundan, Riya Karmakar, Binusha Fathima Sanbatcha, Chien-Wei Huang, Wei-Chun Weng, Hsiang-Chen Wang","doi":"10.3390/bioengineering12060613","DOIUrl":null,"url":null,"abstract":"<p><p>Capsule endoscopy (CE) has revolutionized gastrointestinal (GI) diagnostics by providing a non-invasive, patient-centered approach to observing the digestive tract. Conceived in 2000 by Gavriel Iddan, CE employs a diminutive, ingestible capsule containing a high-resolution camera, LED lighting, and a power supply. It specializes in visualizing the small intestine, a region frequently unreachable by conventional endoscopy. CE helps detect and monitor disorders, such as unexplained gastrointestinal bleeding, Crohn's disease, and cancer, while presenting a lower procedural risk than conventional endoscopy. Contrary to conventional techniques that necessitate anesthesia, CE reduces patient discomfort and complications. Nonetheless, its constraints, specifically the incapacity to conduct biopsies or therapeutic procedures, have spurred technical advancements. Five primary types of capsule endoscopes have emerged: steerable, magnetic, robotic, tethered, and hybrid. Their performance varies substantially. For example, the image sizes vary from 256 × 256 to 640 × 480 pixels, the fields of view (FOV) range from 140° to 360°, the battery life is between 8 and 15 h, and the frame rates fluctuate from 2 to 35 frames per second, contingent upon motion-adaptive capture. This study addresses a significant gap by methodically evaluating CE platforms, outlining their clinical preparedness, and examining the underexploited potential of artificial intelligence in improving diagnostic precision. Through the examination of technical requirements and clinical integration, we highlight the progress made in overcoming existing CE constraints and outline prospective developments for next-generation GI diagnostics.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189750/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060613","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Capsule endoscopy (CE) has revolutionized gastrointestinal (GI) diagnostics by providing a non-invasive, patient-centered approach to observing the digestive tract. Conceived in 2000 by Gavriel Iddan, CE employs a diminutive, ingestible capsule containing a high-resolution camera, LED lighting, and a power supply. It specializes in visualizing the small intestine, a region frequently unreachable by conventional endoscopy. CE helps detect and monitor disorders, such as unexplained gastrointestinal bleeding, Crohn's disease, and cancer, while presenting a lower procedural risk than conventional endoscopy. Contrary to conventional techniques that necessitate anesthesia, CE reduces patient discomfort and complications. Nonetheless, its constraints, specifically the incapacity to conduct biopsies or therapeutic procedures, have spurred technical advancements. Five primary types of capsule endoscopes have emerged: steerable, magnetic, robotic, tethered, and hybrid. Their performance varies substantially. For example, the image sizes vary from 256 × 256 to 640 × 480 pixels, the fields of view (FOV) range from 140° to 360°, the battery life is between 8 and 15 h, and the frame rates fluctuate from 2 to 35 frames per second, contingent upon motion-adaptive capture. This study addresses a significant gap by methodically evaluating CE platforms, outlining their clinical preparedness, and examining the underexploited potential of artificial intelligence in improving diagnostic precision. Through the examination of technical requirements and clinical integration, we highlight the progress made in overcoming existing CE constraints and outline prospective developments for next-generation GI diagnostics.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering